Physician

Navtej S Brar, D.O.

According to 2025 Medicare claims, Navtej Brar, D.O. (NPI: 1255515292) practices cardiology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is CARDIO PULMONARY DIAGNOSTIC LLC (NPI: 1023112638; TIN: 200902110) and primary practice location at 07202-5900. Brar is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247) and St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Brar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,580 traditional Medicare patients, billed 6,777 HCPCS/CPT codes, and received $322,697 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,246 prescription claims across 569 beneficiaries totaling $670,019 in drug costs, led by Eliquis (Apixaban). 2016 DME data shows 170 claims. Open Payments data shows 6 records totaling $99. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $224,048 and ending at $322,697. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $67,373 to $670,019. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,232	3,642	$224,048
2016	1,488	4,110	$224,922
2017	1,586	4,739	$297,054
2018	1,811	5,477	$302,626
2019	1,542	4,722	$206,501
2020	1,445	4,413	$176,750
2021	1,391	4,122	$191,103
2022	1,205	3,516	$158,642
2023	1,327	4,539	$160,242
2024	1,580	6,777	$322,697

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	111	859	$67,373
2016	143	1,280	$114,714
2017	182	1,564	$134,213
2018	265	2,315	$242,947
2019	371	3,028	$332,618
2020	396	3,507	$412,237
2021	402	3,645	$474,464
2022	448	3,786	$557,299
2023	467	3,523	$586,036
2024	569	4,246	$670,019

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	62	223	$7,261
2016	N/R	170	$5,084
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	503	508	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	443	642	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	253	301	$75
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	620	749	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	529	815	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	405	19,522	$371,122
Xarelto	Rivaroxaban	89	4,450	$78,436
Entresto	Sacubitril/Valsartan	43	2,310	$48,180
Jardiance	Empagliflozin	35	1,584	$31,177
Ozempic	Semaglutide	16	482	$14,973

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$99	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Navtej S. Brar, D.O.?

Tedicare shows public-source Medicare data for Navtej S. Brar, D.O. (NPI 1255515292), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Navtej S. Brar, D.O. have ACO affiliation data?

Navtej S. Brar, D.O. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247) and St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Navtej S. Brar, D.O.?

Navtej S. Brar, D.O. is linked to CARDIO PULMONARY DIAGNOSTIC LLC (billing NPI 1023112638) in the available physician profile data.

Does Navtej S. Brar, D.O. have Open Payments data?

Navtej S. Brar, D.O. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.